Tag: GRC 54276

Glenmark Pharmaceuticals set to begin clinical trial of GRC 54276 in US

businessnewstoday- March 17, 2023

Glenmark Pharmaceuticals, through its subsidiary Glenmark Specialty, is set to begin a first-in-human, phase 1/2 clinical study of GRC 54276 in the US for the ... Read More